Skip to main content
  • Pharmacogenomics in Intracranial Atherosclerotic Disease-CYP2C19 Loss-Of-Function is Associated with Increased Risk of First-time Ischemic Stroke

    Abstract Final #: 246

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy